Article
Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 May 2015
Lohinai Zoltan, Hoda Mir Alireza, Fabian Katalin, Ostoros Gyula, Raso Erzsebet, Barbai Tamas, Timar Jozsef, Kovalszky Ilona, Cserepes Mihaly, Rozsas Anita, Laszlo Viktoria, Grusch Michael, Berger Walter, Klepetko Walter, Moldvay Judit, Dome Balazs, Hegedus Balazs
Abstract excerpt
INTRODUCTION: Although classic sensitizing mutations of epidermal growth factor receptor (EGFR) are positive predictive markers for EGFR tyrosine kinase inhibitors (TKIs) in lung adenocarcinoma, there are rare EGFR mutations with unknown epidemiology and influence on prognosis and TKI response. METHODS: Eight hundred and fourteen lung adenocarcinoma patients with KRAS and/or EGFR mutation analyses for TKI therapy...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
